Epithelial-mesenchymal transition-related gene prognostic index and phenotyping clusters for hepatocellular carcinoma patients.

[1]  R. Jia,et al.  Novel insights into RB1 mutation. , 2022, Cancer letters.

[2]  G. Papatheodoridis,et al.  Hepatocellular carcinoma: the virus or the liver? , 2022, Liver international : official journal of the International Association for the Study of the Liver.

[3]  M. Berridge,et al.  Bioenergetic and Metabolic Adaptation in Tumor Progression and Metastasis , 2022, Frontiers in Oncology.

[4]  Yinwei Qu,et al.  Identification of Prognosis Biomarkers for High-Grade Serous Ovarian Cancer Based on Stemness , 2022, Frontiers in Genetics.

[5]  Xiangwen Ji,et al.  The clinical relevance of epithelial‐mesenchymal transition and its correlations with tumorigenic immune infiltrates in hepatocellular carcinoma , 2022, Immunology.

[6]  J. Gulley,et al.  Tumor in the Crossfire: Inhibiting TGF-β to Enhance Cancer Immunotherapy , 2022, BioDrugs.

[7]  F. Marcucci,et al.  Tumor Cell Glycolysis—At the Crossroad of Epithelial–Mesenchymal Transition and Autophagy , 2022, Cells.

[8]  D. Pattabiraman,et al.  Quantifying the Epithelial-to-Mesenchymal Transition (EMT) from Bench to Bedside , 2022, Cancers.

[9]  Jiaxuan Chen,et al.  Implications of Stemness Features in 1059 Hepatocellular Carcinoma Patients from Five Cohorts: Prognosis, Treatment Response, and Identification of Potential Compounds , 2022, Cancers.

[10]  N. Girard,et al.  Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers. , 2022, Lung cancer.

[11]  Dongjie Chen,et al.  Integrated Machine Learning and Bioinformatic Analyses Constructed a Novel Stemness-Related Classifier to Predict Prognosis and Immunotherapy Responses for Hepatocellular Carcinoma Patients , 2022, International journal of biological sciences.

[12]  Zijian Liu,et al.  m6A Regulators Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization In Nasopharyngeal Carcinoma , 2022, Frontiers in Immunology.

[13]  Baorui Liu,et al.  Comparative Analysis of Predictive Biomarkers for PD-1/PD-L1 Inhibitors in Cancers: Developments and Challenges , 2021, Cancers.

[14]  G. Brandi,et al.  Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy in Hepatocellular Carcinoma: Where Do We Stand? , 2021, Frontiers in Oncology.

[15]  B. Baradaran,et al.  Exploiting systems biology to investigate the gene modules and drugs in ovarian cancer: A hypothesis based on the weighted gene co-expression network analysis. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[16]  I. Moriyama,et al.  The Epithelial–Mesenchymal Transition Influences the Resistance of Oral Squamous Cell Carcinoma to Monoclonal Antibodies via Its Effect on Energy Homeostasis and the Tumor Microenvironment , 2021, Cancers.

[17]  Linzhi Han,et al.  Tumor stemness and immune infiltration synergistically predict response of radiotherapy or immunotherapy and relapse in lung adenocarcinoma , 2021, Cancer medicine.

[18]  G. Sethi,et al.  Wnt/β-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular Pathways , 2021, Journal of hepatocellular carcinoma.

[19]  S. Savage,et al.  Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study. , 2021, The Lancet. Oncology.

[20]  K. Cao,et al.  CD8+ T effector and immune checkpoint signatures predict prognosis and responsiveness to immunotherapy in bladder cancer , 2021, Oncogene.

[21]  J. Squire,et al.  The Role of Somatic Mutations on the Immune Response of the Tumor Microenvironment in Prostate Cancer , 2021, International journal of molecular sciences.

[22]  Tao Luo,et al.  Signature of prognostic epithelial–mesenchymal transition related long noncoding RNAs (ERLs) in hepatocellular carcinoma , 2021, Medicine.

[23]  Lijun Xu,et al.  A Novel Expression Signature from the Perspective of Mesenchymal-Epithelial Transition for Hepatocellular Carcinoma with Regard to Prognosis, Clinicopathological Features, Immune Cell Infiltration, Chemotherapeutic Efficacy, and Immunosuppressive Molecules , 2021, Journal of oncology.

[24]  Xiaochen Bo,et al.  clusterProfiler 4.0: A universal enrichment tool for interpreting omics data , 2021, Innovation.

[25]  Y. Yarden,et al.  TP53 missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment , 2021, Proceedings of the National Academy of Sciences.

[26]  N. Almog,et al.  Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. , 2021, Cancer cell.

[27]  K. Tomczak,et al.  Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing , 2021, Proceedings of the National Academy of Sciences.

[28]  Haihua Yang,et al.  Development and validation of epithelial mesenchymal transition-related prognostic model for hepatocellular carcinoma , 2021, Aging.

[29]  Minqi Li,et al.  m6A regulator‐mediated RNA methylation modification patterns are involved in immune microenvironment regulation of periodontitis , 2021, Journal of cellular and molecular medicine.

[30]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[31]  J. Zucman‐Rossi,et al.  Hepatocellular carcinoma , 1998, Nature Reviews Disease Primers.

[32]  A. Villanueva,et al.  Signaling pathways in hepatocellular carcinoma. , 2021, Advances in cancer research.

[33]  M. Dai,et al.  [Disease burden of liver cancer in China: an updated and integrated analysis on multi-data source evidence]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[34]  Zhiyong Li,et al.  An Immune-Related Gene Prognostic Index for Head and Neck Squamous Cell Carcinoma , 2020, Clinical Cancer Research.

[35]  T. Efferth,et al.  Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance. , 2020, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[36]  Song Wu,et al.  Immune Cell Confrontation in the Papillary Thyroid Carcinoma Microenvironment , 2020, Frontiers in Endocrinology.

[37]  Ping Huang,et al.  Comprehensive Analysis of the PD-L1 and Immune Infiltrates of m6A RNA Methylation Regulators in Head and Neck Squamous Cell Carcinoma , 2020, Molecular therapy. Nucleic acids.

[38]  X. Liu,et al.  Large-scale public data reuse to model immunotherapy response and resistance , 2020, Genome Medicine.

[39]  Min Zhao,et al.  dbEMT 2.0: An updated database for epithelial-mesenchymal transition genes with experimentally verified information and precalculated regulation information for cancer metastasis. , 2019, Journal of genetics and genomics = Yi chuan xue bao.

[40]  Tulika Kakati,et al.  Comparison of Methods for Differential Co-expression Analysis for Disease Biomarker Prediction , 2019, Comput. Biol. Medicine.

[41]  Reem Saleh,et al.  Treg-mediated acquired resistance to immune checkpoint inhibitors. , 2019, Cancer letters.

[42]  G. Stassi,et al.  Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance , 2019, Molecular Cancer.

[43]  Y. Liao,et al.  Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures , 2019, Cancer Immunology Research.

[44]  C. Blanpain,et al.  EMT Transition States during Tumor Progression and Metastasis. , 2019, Trends in cell biology.

[45]  Lei Chen,et al.  HCCDB: A Database of Hepatocellular Carcinoma Expression Atlas , 2018, Genom. Proteom. Bioinform..

[46]  Joshua M. Stuart,et al.  Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation. , 2018, Cell.

[47]  Petra Koudelkova,et al.  Role of epithelial to mesenchymal transition in hepatocellular carcinoma. , 2016, Journal of hepatology.

[48]  Emanuel J. V. Gonçalves,et al.  A Landscape of Pharmacogenomic Interactions in Cancer , 2016, Cell.

[49]  J. Mesirov,et al.  The Molecular Signatures Database Hallmark Gene Set Collection , 2015 .

[50]  Paul Geeleher,et al.  pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels , 2014, PloS one.

[51]  Sridhar Ramaswamy,et al.  Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells , 2012, Nucleic Acids Res..

[52]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.